Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Bright Minds Biosciences | 454.81 Mn | 232.27 Mn | - | 286,337.69 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 286,337.69 |
| Mar 31, 2026 | 545,982.55 |
| Dec 31, 2025 | 252,080.21 |
| Sep 30, 2025 | 192,089.60 |
| Jun 30, 2025 | 119,442.70 |
| Mar 31, 2025 | 192,806.12 |
| Dec 31, 2024 | 55,526.99 |
| Sep 30, 2024 | 35,498.11 |
| Jun 30, 2024 | 59,401.51 |
| Mar 31, 2024 | 41,532.37 |
| Dec 31, 2023 | 50,856.30 |
| Sep 30, 2023 | -34,252.38 |
| Jun 30, 2023 | 90,855.96 |
| Mar 31, 2023 | 103,552.31 |
| Dec 31, 2022 | 46,183.91 |
| Sep 30, 2022 | 78,105.37 |
| Jun 30, 2022 | 71,207.15 |
| Mar 31, 2022 | 58,374.60 |
| Dec 31, 2021 | 167,913.55 |
| Sep 30, 2021 | 72,973.64 |